Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acid Reflux Disease Therapy
Research results from University of Connecticut, Health Center update understanding of acid reflux disease therapy
April 6th, 2008
Researchers detail in 'Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease,' new data in acid reflux disease. Researchers in the United States conducted a study "To report the use of pH-impedance testing in evaluating patients with suspected gastroesophageal reflux disease (GERD) with atypical symptoms. Although the role of acid reflux in causing atypical GERD symptoms is generally accepted, the role, if any, of nonacid reflux is controversial, largely because until recently it has not been possible to detect nonacid reflux." "The advent of intraluminal combined pH impedance testing (MII-pH),...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
